Department of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.
Department of Nursing, Changchun University of Chinese Medicine, Changchun, China.
Medicine (Baltimore). 2021 Nov 24;100(47):e27963. doi: 10.1097/MD.0000000000027963.
The purpose of this study was to evaluate the effectiveness and safety of electroacupuncture combined with rehabilitation in the treatment of spasticity after stroke.
To collect relevant literature, we will research following databases: Medicine, PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure, Wan-Fang Database, Chongqing VIP Chinese Science and Technology Periodicals Database and China Biomedical Database; the time is from its creation to May 2021, and the language is limited to Chinese and English. In addition, we will retrieve other literature resources, including the Chinese Clinical Trial Register and conference papers. Two reviewers will independently complete the literature screen and data extraction, and quality assessment of the included studies will be independently completed by two other researchers. The primary outcomes included the Modified Ashworth scale (MAS) and the simplified Fugl-Meyer Assessment scale (SFMA). The Modified Barthel Index (MBI), the China Stroke Scale (CSS), and adverse reactions as secondary outcomes were assessed. RevMan V.5.4.1 software will be used for meta-analysis, and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) will be used to assess the quality of evidence.
This systematic review will provide a high-quality synthesis to evaluate the efficacy and safety of electroacupuncture combined with rehabilitation therapy in the treatment of upper limb spasticity after stroke, providing a reference for the safe and effective treatment of upper limb spasm after stroke.
This study provides evidence that electroacupuncture combined with rehabilitation therapy is effective.
The protocol of the systematic review does not require ethical approval because it does not involve humans. This article will be published in peer-reviewed journals and presented at relevant conferences.
INPLASY202160005.
本研究旨在评估电针结合康复治疗脑卒中后痉挛的有效性和安全性。
为收集相关文献，我们将检索以下数据库：医学、PubMed、Embase、Web of Science、Cochrane 图书馆、中国知网、万方数据库、重庆维普中文科技期刊数据库和中国生物医学文献数据库；时间从创建到 2021 年 5 月，语言限于中文和英文。此外，我们将检索其他文献资源，包括中国临床试验注册中心和会议论文。两名评审员将独立完成文献筛选和数据提取，两名其他研究人员将独立完成纳入研究的质量评估。主要结局指标包括改良 Ashworth 量表（MAS）和简化 Fugl-Meyer 评估量表（SFMA）。次要结局指标包括改良巴氏指数（MBI）、中国脑卒中量表（CSS）和不良反应。RevMan V.5.4.1 软件将用于荟萃分析，推荐评估、制定与评价（GRADE）将用于评估证据质量。
本系统评价将提供高质量的综合评价，以评估电针结合康复治疗脑卒中后上肢痉挛的疗效和安全性，为脑卒中后上肢痉挛的安全有效治疗提供参考。
本研究提供了电针结合康复治疗有效的证据。
本系统评价方案不需要伦理批准，因为它不涉及人类。本文将发表在同行评议期刊上，并在相关会议上发表。
INPLASY202160005。
